- Home
- Polaris Venture Partners Special Founders' Fund V, L.p.
Insider Trading History of Polaris Venture Partners Special Founders' Fund V, L.p.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Polaris Venture Partners Special Founders' Fund V, L.p. since 2013.
The trader's CIK number is 1439586.
At the time of the last reporting, Polaris Venture Partners Special Founders' Fund V, L.p. was the 10% Owner of Cardlytics, Inc.. (stock ticker symbol CDLX).
Also see all insider trading activities at Cardlytics, Inc..
Note that in the past
Polaris Venture Partners Special Founders' Fund V, L.P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fate Therapeutics Inc (FATE) by Polaris Venture Partners Special Founders' Fund V, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | FATE | 833,333 | $4,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dare Bioscience, Inc. (CERU) by Polaris Venture Partners Special Founders' Fund V, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | CERU | 1,470,582 | $10,294,074 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Polaris Venture Partners Special Founders' Fund V, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | GNCA | 0 | $0 | 86,622 | $1,138,392 | 0 | $0 |
| 2014 | GNCA | 0 | $0 | 73,454 | $972,904 | 0 | $0 |
Yearly summary of insider trading at Selecta Biosciences Inc (SELB) by Polaris Venture Partners Special Founders' Fund V, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | SELB | 150,000 | $2,100,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pulmatrix, Inc. (PULM) by Polaris Venture Partners Special Founders' Fund V, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | PULM | 1,150,000 | $0 | 0 | $0 | 0 | $0 |
| 2015 | PULM | 106,693 | $733,514 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cardlytics, Inc. (CDLX) by Polaris Venture Partners Special Founders' Fund V, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CDLX | 0 | $0 | 344,011 | $8,572,491 | 0 | $0 |
| 2018 | CDLX | 0 | $0 | 150,000 | $3,791,150 | 66,364 | $0 |
Yearly summary of insider trading at Ocular Therapeutix, Inc (OCUL) by Polaris Venture Partners Special Founders' Fund V, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | OCUL | 0 | $0 | 500,000 | $14,750,000 | 0 | $0 |
Insider trading activities at 7 companies by Polaris Venture Partners Special Founders' Fund V, L.p.:
1. Fate Therapeutics Inc (FATE)
2. Dare Bioscience, Inc. (CERU)
3. Genocea Biosciences, Inc. (GNCA)
4. Selecta Biosciences Inc (SELB)
5. Pulmatrix, Inc. (PULM)
6. Cardlytics, Inc. (CDLX)
7. Ocular Therapeutix, Inc (OCUL)
Table 1. Insider trading of Fate Therapeutics Inc (FATE) by Polaris Venture Partners Special Founders' Fund V, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-10-04 | FATE | Buy | 833,333 | 6.00 | 4,999,998 |
Table 2. Insider trading of Dare Bioscience, Inc. (CERU) by Polaris Venture Partners Special Founders' Fund V, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-04-15 | CERU | Buy | 1,470,582 | 7.00 | 10,294,074 |
Table 3. Insider trading of Genocea Biosciences, Inc. (GNCA) by Polaris Venture Partners Special Founders' Fund V, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-06-18 | GNCA | Sale | 29,004 | 13.04 | 378,212 |
| 2015-06-19 | GNCA | Sale | 1,000 | 13.00 | 13,000 |
| 2015-06-16 | GNCA | Sale | 46,000 | 13.24 | 609,040 |
| 2015-06-17 | GNCA | Sale | 10,618 | 13.01 | 138,140 |
| 2014-08-14 | GNCA | Sale | 6,755 | 13.01 | 87,882 |
| 2014-08-13 | GNCA | Sale | 2,905 | 13.00 | 37,765 |
| 2014-08-08 | GNCA | Sale | 41,376 | 13.41 | 554,852 |
| 2014-08-11 | GNCA | Sale | 1,428 | 13.24 | 18,906 |
| 2014-08-12 | GNCA | Sale | 20,990 | 13.03 | 273,499 |
Table 4. Insider trading of Selecta Biosciences Inc (SELB) by Polaris Venture Partners Special Founders' Fund V, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-06-27 | SELB | Buy | 150,000 | 14.00 | 2,100,000 |
Table 5. Insider trading of Pulmatrix, Inc. (PULM) by Polaris Venture Partners Special Founders' Fund V, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-04-03 | PULM | Buy | 1,150,000 | .00 | 0 |
| 2015-06-15 | PULM | Buy | 106,693 | 6.88 | 733,514 |
Table 6. Insider trading of Cardlytics, Inc. (CDLX) by Polaris Venture Partners Special Founders' Fund V, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-07-15 | CDLX | Sale | 19,984 | 27.73 | 554,076 |
| 2019-07-16 | CDLX | Sale | 20,962 | 27.87 | 584,189 |
| 2019-07-17 | CDLX | Sale | 27,781 | 27.45 | 762,505 |
| 2019-06-07 | CDLX | Sale | 100,000 | 25.62 | 2,562,100 |
| 2019-06-06 | CDLX | Sale | 305 | 25.00 | 7,625 |
| 2019-06-05 | CDLX | Sale | 38,601 | 24.64 | 951,244 |
| 2019-06-04 | CDLX | Sale | 36,378 | 23.28 | 846,952 |
| 2019-05-28 | CDLX | Sale | 100,000 | 23.04 | 2,303,800 |
| 2018-09-12 | CDLX | Sale | 100,000 | 24.93 | 2,492,900 |
| 2018-09-13 | CDLX | Sale | 50,000 | 25.96 | 1,298,250 |
| 2018-08-09 | CDLX | Option Ex | 66,364 | .00 | 0 |
Table 7. Insider trading of Ocular Therapeutix, Inc (OCUL) by Polaris Venture Partners Special Founders' Fund V, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-02-02 | OCUL | Sale | 500,000 | 29.50 | 14,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Polaris Venture Partners Special Founders' Fund V, L.p.
(10% Owner of Cardlytics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.